News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech GlobeImmune, Inc. Withdraws $60 Million IPO


11/1/2013 7:44:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlobeImmune, which is developing therapeutic drugs for pancreatic cancer and hepatitis B and C, withdrew its plans for an initial public offering on Thursday citing poor market conditions. The Louisville, CO-based company was founded in 1995 and last updated its filing on September 5, 2012.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at News Release
Read at News Release
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES